Suppr超能文献

线粒体钙离子摄取受到p38丝裂原活化蛋白激酶和蛋白激酶D的协同作用抑制。

Mitochondrial Ca2+ uptake is inhibited by a concerted action of p38 MAPK and protein kinase D.

作者信息

Koncz Péter, Szanda Gergo, Fülöp László, Rajki Anikó, Spät András

机构信息

Department of Physiology, Faculty of Medicine, Semmelweis University and Laboratory of Neurobiochemistry and Molecular Physiology, Hungarian Academy of Sciences, P.O. Box 259, H-1444 Budapest, Hungary.

出版信息

Cell Calcium. 2009 Aug;46(2):122-9. doi: 10.1016/j.ceca.2009.06.004. Epub 2009 Jul 24.

Abstract

Angiotensin II elicits cytosolic Ca2+ signal that is transferred into the mitochondria. Previously we found in H295R cells that this signal transfer is enhanced by both the inhibition of p38 MAPK and a novel isoform of PKC [G. Szanda, P. Koncz, A. Rajki, A. Spät, Participation of p38 MAPK and a novel-type protein kinase C in the control of mitochondrial Ca2+ uptake, Cell Calcium 43 (2008) 250-259]. Now we report that simultaneous activation of these protein kinases (by TNFalpha and PMA+an inhibitor of the conventional PKC isoforms, respectively) attenuates the transfer of cytosolic Ca2+ signal, elicited by depolarisation or store-operated Ca2+ influx, into the mitochondria. The Ca2+ uptake enhancing effect of the p38 MAPK inhibitor SB202190 is due to the inhibition of p38 MAPK and not to a direct mitochondrial action. Protein kinases reduce mitochondrial [Ca2+] by inhibiting the uptake mechanism. The threshold of mitochondrial Ca2+ uptake may depend on the activity of p38 MAPK. The silencing of protein kinase D (PKD) also results in enhanced transfer of Ca2+ signal from the cytosol into the mitochondria. Our data indicate that Ca2+ mobilising agonists, through the simultaneous activation of p38 MAPK, a novel PKC isoform and PKD, exert a negative feed-forward action on mitochondrial Ca2+ uptake, thus reducing the risk of Ca2+ overload.

摘要

血管紧张素II引发细胞溶质Ca2+信号,该信号会传递到线粒体中。此前我们在H295R细胞中发现,p38丝裂原活化蛋白激酶(p38 MAPK)的抑制作用和一种新型蛋白激酶C(PKC)亚型均可增强这种信号传递[G. 桑达、P. 孔茨、A. 拉伊基、A. 施帕特,p38 MAPK和新型蛋白激酶C在控制线粒体Ca2+摄取中的作用,《细胞钙》43卷(2008年)第250 - 259页]。现在我们报告,同时激活这些蛋白激酶(分别通过肿瘤坏死因子α(TNFalpha)和佛波酯(PMA)+传统PKC亚型抑制剂)会减弱由去极化或储存性钙内流引发的细胞溶质Ca2+信号向线粒体的传递。p38 MAPK抑制剂SB202190增强Ca2+摄取的作用是由于对p38 MAPK的抑制,而非直接作用于线粒体。蛋白激酶通过抑制摄取机制降低线粒体[Ca2+]。线粒体Ca2+摄取的阈值可能取决于p38 MAPK的活性。蛋白激酶D(PKD)的沉默也会导致Ca2+信号从细胞溶质向线粒体的传递增强。我们的数据表明,Ca2+动员激动剂通过同时激活p38 MAPK、一种新型PKC亚型和PKD,对线粒体Ca2+摄取发挥负反馈前馈作用,从而降低Ca2+过载的风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验